跳至主導覽 跳至搜尋 跳過主要內容

Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases

  • Jeng Feng Lin
  • , Semon Wu
  • , Jyh Ming J. Juang
  • , Fu Tien Chiang
  • , Lung An Hsu
  • , Ming Sheng Teng
  • , Shih Tsung Cheng
  • , Hsuan Li Huang
  • , Yu Lin Ko*
  • *此作品的通信作者
  • Buddhist Tzu Chi Medical Foundation
  • Tzu Chi University
  • Chinese Culture University
  • National Taiwan University

研究成果: 期刊稿件 › 文章 › 同行評審

19 引文 斯高帕斯(Scopus)

摘要

Aim: This study aims to investigate whether osteoprotegerin (OPG) or osteopontin (OPN) single nucleotide polymorphisms (SNPs) will predict survival. Materials & methods: This study enrolled 617 participants undergoing health examination, 536 coronary artery disease (CAD) patients and 86 peripheral artery disease (PAD) patients. Genotypes of OPG SNP rs2073618 and OPN SNP rs11730582 were determined. OPG and OPN levels were measured. Results: In both CAD and PAD populations, high OPG and OPN levels were strong predictors of all-cause death. The OPG rs2073618 CC genotype and the OPN rs11730582 TT genotype did not predict mortality. Conclusion: High OPG and high OPN levels, but not OPG rs2073618 CC genotype or OPN rs11730582 TT genotype, were strong predictors of mortality in both CAD and PAD patients.

原文英語
頁(從 - 到)751-760
頁數10
期刊Biomarkers in Medicine
卷13
發行號9
DOIs
出版狀態已出版 - 2019

文獻附註

Publisher Copyright:
© 2019 Future Medicine Ltd.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases」主題。共同形成了獨特的指紋。

引用此